公开(公告)号：WO2017040896A1

公开(公告)日：2017-03-09

申请号：PCT/US2016/050055

申请日：2016-09-02

申请人： ABBVIE INC.

发明人： CHEN, Hui-Ju, J. ,  DEGOEY, David, A. ,  KALTHOD, Vikram ,  KRUEGER, Allan, C. ,  RANDOLPH, John, T. ,  WAGNER, Rolf

IPC分类号： A61K31/513 ,  A61K31/7072 ,  C07D239/04 ,  C07D403/04 ,  C07F9/06 ,  C07H19/10

CPC分类号： A61K31/7072 ,  A61K45/06 ,  C07D303/04 ,  C07D303/08 ,  C07D491/107 ,  C07D493/10 ,  C07F9/65586 ,  C07F9/6561 ,  C07H19/10 ,  A61K2300/00

摘要： The present invention features compounds effective in inhibiting active against Hepatitis C virus ("HCV") polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

公开(公告)号：WO2017040895A1

公开(公告)日：2017-03-09

申请号：PCT/US2016/050054

申请日：2016-09-02

申请人： ABBVIE INC.

发明人： CHEN, Hui-Ju, J. ,  DEGOEY, David, A. ,  KALTHOD, Vikram ,  KRUEGER, Allan, C. ,  RANDOLPH, John, T. ,  WAGNER, Rolf

IPC分类号： A61K31/513 ,  A61K31/7072 ,  C07D239/04 ,  C07D403/04 ,  C07F9/06 ,  C07H19/10

CPC分类号： A61K31/7072 ,  A61K45/06 ,  C07D239/54 ,  C07D405/04 ,  C07F9/65121 ,  C07F9/65586 ,  C07H19/10 ,  A61K2300/00

摘要： The present invention features compounds effective in inhibiting active against Hepatitis C virus ("HCV") polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

公开(公告)号：WO2017040892A1

公开(公告)日：2017-03-09

申请号：PCT/US2016/050051

申请日：2016-09-02

申请人： ABBVIE INC.

发明人： CHEN, Hui-Ju, J. ,  DEGOEY, David, A. ,  KALTHOD, Vikram ,  KRUEGER, Allan, C. ,  RANDOLPH, John, T. ,  WAGNER, Rolf

IPC分类号： A61K31/513 ,  A61K31/7072 ,  C07D239/04 ,  C07D403/04 ,  C07F9/06 ,  C07H19/10

CPC分类号： C07H19/10 ,  C07D239/54 ,  C07D403/04 ,  C07F9/65121 ,  C07F9/65583 ,  C07F9/65586 ,  C07F9/6561

摘要： The present invention features compounds effective in inhibiting active against Hepatitis C virus ("HCV") polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.